BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland,…
Company has initiated Phase I/II AFFINITY DUCHENNE™ trial of RGX-202 Company also enrolling newly active observational screening study, AFFINITY BEYOND, evaluating…